$RHHBY ($ONCE)

Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A at #ISTH2020
https://t.co/HuRwNWktDn

Phase 3 DOSING expected to start in 2021.

If they are STILL optimizing they likely had/still have some serious immunogenicity concerns! 

$BMRN $SGMO $PFE